title: Characterization of a graded cervical hemicontusion spinal cord injury model in adult male rats.
abstract: Most experimental models of spinal cord injury (SCI) in rodents induce damage in the thoracic cord and subsequently examine hindlimb function as an indicator of recovery. In these models, functional recovery is most attributable to white-matter preservation and is less influenced by grey-matter sparing. In contrast, most clinical cases of SCI occur at the lower cervical levels, a region in which both grey-matter and white-matter sparing contribute to functional motor recovery. Thus experimental cervical SCI models are beginning to be developed and used to assess protective and pharmacological interventions following SCI. The objective of this study was to characterize a model of graded cervical hemicontusion SCI with regard to several histological and behavioral outcome measures, including novel forelimb behavioral tasks. Using a commercially available rodent spinal cord impactor, adult male rats received hemicontusion SCI at vertebral level C5 at 100, 200, or 300 kdyn force, to produce mild, moderate, or severe injury severities. Tests of skilled and unskilled forelimb and locomotor function were employed to assess functional recovery, and spinal cord tissue was collected to assess lesion severity. Deficits in skilled and unskilled forelimb function and locomotion relating to injury severity were observed, as well as decreases in neuronal numbers, white-matter area, and white-matter gliosis. Significant correlations were observed between behavioral and histological data. Taken together, these data suggest that the forelimb functional and locomotor assessments employed here are sensitive enough to measure functional changes, and that this hemicontusion model can be used to evaluate potential protective and regenerative therapeutic strategies.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Center for Glial Biology in Medicine, University of Alabama-Birmingham, Birmingham, Alabama 35249, USA.
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Dunham
authors.forename: Akkradate
authors.initials: A
authors.lastname: Siriphorn
authors.forename: Supin
authors.initials: S
authors.lastname: Chompoopong
authors.forename: Candace L
authors.initials: CL
authors.lastname: Floyd
mesh_terms: D000818:Animals; D048588:Benzoxazines; D002452:Cell Count; D003288:Contusions / Q000473:pathology* / Q000523:psychology*; D004195:Disease Models, Animal; D005453:Fluorescence; D005552:Forelimb / Q000502:physiology; D007839:Functional Laterality / Q000502:physiology; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005911:Gliosis / Q000473:pathology; D006262:Health; D007150:Immunohistochemistry; D008124:Locomotion / Q000502:physiology; D008297:Male; D009048:Motor Skills / Q000502:physiology; D004676:Myelin Basic Protein / Q000378:metabolism; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000473:pathology; D010078:Oxazines; D011597:Psychomotor Performance / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020127:Recovery of Function; D013116:Spinal Cord / Q000473:pathology; D013119:Spinal Cord Injuries / Q000473:pathology* / Q000523:psychology*
chemical_list: D048588:Benzoxazines; D005904:Glial Fibrillary Acidic Protein; D004676:Myelin Basic Protein; D010078:Oxazines; C028911:cresyl violet